Focus and Coverage
The Journal of Pharmacology and Pharmacotherapeutics (JPP) is an open access, peer reviewed journal which publishes high-quality articles pertaining to basic research and clinical studies in the domains of Pharmacology and Pharmacotherapeutics. Articles are freely accessible online in perpetuity under a Creative Commons License.
Contents from Current Issue
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundPatients with acute promyelocytic leukemia (APML) undergoing induction therapy are severely immunocompromised and prone to opportunistic infections. Tuberculosis (TB), though less commonly considered, can complicate the clinical course, …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundMRSA and PRSP resistance has surged over 30 years, threatening clinical outcomes; China-developed cefathiamidine sodium, with enhanced pharmacokinetics, offers potent activity against these Gram-positive pathogens.PurposeThis study evaluates the …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundBuprofezin, a thiadiazine insecticide globally recognized as a molting inhibitor, is widely used for controlling whitefly and other insect pests.PurposeThis study investigated the impacts of sub-lethal buprofezin concentrations (0.15, 0.30, and …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundDown syndrome (DS), caused by trisomy 21, is characterized by chronic oxidative stress resulting from overexpression of the superoxide dismutase 1 (SOD1) gene without a proportional increase in downstream antioxidant enzymes such as glutathione …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare yet debilitating neuropathy characterized by chronic inflammation, demyelination, and axonal degeneration. Current treatments, including corticosteroids, intravenous …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundDoxorubicin (DOX), an anthracycline-based chemotherapeutic agent, has been widely used as a first-line treatment for several cancers, including hematological and solid tumors, but its clinical utility is limited by severe cardiotoxicity and …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundOsteoarthritis (OA) is the most common form of arthritis affecting the elderly and obese population, and requires long-term medical management. Inflammatory pathways, possibly initiated by tissue damage and stress are involved in the …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundTraditional teaching methods can pose challenges for learners, particularly when it comes to applying theoretical knowledge in practical settings. In contrast, Peyton’s four-step approach provides a structured, learner-centered framework that …Read Original Source
